Table 1 The demographic, baseline clinical characteristics of the patients

Sex, number (percent)

  Male

74(75.5)

  Female

24(24.5)

Age, mean(SD), years

40.26 ± 8.99

Injection drug abuse, number (percent)

  Yes

55(56.1)

  No

43(43.9)

Duration since HIV diagnosis, median (range), month

26.5 (3–152)

Chronic hepatitis B, number (percent)

  Yes

6(6.1)

  No

92(93.9)

Chronic hepatitis C, number (percent)

  Yes

53(54.1)

  No

45(45.9)

GFR, mL/min/1.73 m², number (percent)

  ≥90

75(76.6)

  <90

23(23.4)

Calcium level mg/dl, mean (SD)

8.97 ± 0.40

Phosphorus level mg/dl, mean (SD)

3.25 ± 0.69

Parathyroid hormone level pg/ml, mean (SD)

33.92 ± 17.96

Alkaline phosphatase IU/l, mean (SD)

200.80 ± 72.05

Antiretroviral regimen, number (percent)

  Standard (Zidovudine + lamivudine + Efavirenz)

88(89.7)

  Other

10(10.3)